Autologous conditioned plasma therapy is used to treat a range of problems, such as musculoskeletal injuries, sports injuries and trauma. Today, among other things, it is widely used to treat skin ulcers, sports injuries, and cosmetic surgery. The growing demand for user-friendly treatment procedures is driving the expansion of the autologous conditioned plasma therapy market.
This procedure provides excellent and effective treatment without the need for painful surgery.
This report aims to provide a comprehensive presentation of the global market for Autologous Conditioned Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Conditioned Plasma Therapy. This report contains market size and forecasts of Autologous Conditioned Plasma Therapy in global, including the following market information:
Global Autologous Conditioned Plasma Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autologous Conditioned Plasma Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pure Platelet-Rich Plasma (P-PRP) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autologous Conditioned Plasma Therapy include Zimmer Biomet Inc., Terumo Corporation, AdiStem Ltd., Arthrex, Inc., Stryker Corporation, Cesca Therapeutics, Inc., Biotechnology Institute BTI, Dr. PRP America LLC and EmCyte Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autologous Conditioned Plasma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autologous Conditioned Plasma Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autologous Conditioned Plasma Therapy Market Segment Percentages, by Type, 2022 (%)
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte- and Platelet-Rich Plasma (LPRP)
Pure Platelet-Rich Fibrin (P-PRF)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Global Autologous Conditioned Plasma Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autologous Conditioned Plasma Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Orthopedic & Trauma Centers
Research Institutes
Global Autologous Conditioned Plasma Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autologous Conditioned Plasma Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autologous Conditioned Plasma Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autologous Conditioned Plasma Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zimmer Biomet Inc.
Terumo Corporation
AdiStem Ltd.
Arthrex, Inc.
Stryker Corporation
Cesca Therapeutics, Inc.
Biotechnology Institute BTI
Dr. PRP America LLC
EmCyte Corporation
Vivostat A/S
Regen Lab SA
Royal Biologics
Exactech, Inc.
Plateltex S.R.O.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autologous Conditioned Plasma Therapy, market overview.
Chapter 2: Global Autologous Conditioned Plasma Therapy market size in revenue.
Chapter 3: Detailed analysis of Autologous Conditioned Plasma Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autologous Conditioned Plasma Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autologous Conditioned Plasma Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Conditioned Plasma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Conditioned Plasma Therapy Overall Market Size
2.1 Global Autologous Conditioned Plasma Therapy Market Size: 2022 VS 2029
2.2 Global Autologous Conditioned Plasma Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autologous Conditioned Plasma Therapy Players in Global Market
3.2 Top Global Autologous Conditioned Plasma Therapy Companies Ranked by Revenue
3.3 Global Autologous Conditioned Plasma Therapy Revenue by Companies
3.4 Top 3 and Top 5 Autologous Conditioned Plasma Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Autologous Conditioned Plasma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autologous Conditioned Plasma Therapy Players in Global Market
3.6.1 List of Global Tier 1 Autologous Conditioned Plasma Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Autologous Conditioned Plasma Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autologous Conditioned Plasma Therapy Market Size Markets, 2022 & 2029
4.1.2 Pure Platelet-Rich Plasma (P-PRP)
4.1.3 Leukocyte- and Platelet-Rich Plasma (LPRP)
4.1.4 Pure Platelet-Rich Fibrin (P-PRF)
4.1.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)
4.2 By Type - Global Autologous Conditioned Plasma Therapy Revenue & Forecasts
4.2.1 By Type - Global Autologous Conditioned Plasma Therapy Revenue, 2018-2023
4.2.2 By Type - Global Autologous Conditioned Plasma Therapy Revenue, 2024-2029
4.2.3 By Type - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autologous Conditioned Plasma Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialized Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Orthopedic & Trauma Centers
5.1.6 Research Institutes
5.2 By Application - Global Autologous Conditioned Plasma Therapy Revenue & Forecasts
5.2.1 By Application - Global Autologous Conditioned Plasma Therapy Revenue, 2018-2023
5.2.2 By Application - Global Autologous Conditioned Plasma Therapy Revenue, 2024-2029
5.2.3 By Application - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Autologous Conditioned Plasma Therapy Market Size, 2022 & 2029
6.2 By Region - Global Autologous Conditioned Plasma Therapy Revenue & Forecasts
6.2.1 By Region - Global Autologous Conditioned Plasma Therapy Revenue, 2018-2023
6.2.2 By Region - Global Autologous Conditioned Plasma Therapy Revenue, 2024-2029
6.2.3 By Region - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Autologous Conditioned Plasma Therapy Revenue, 2018-2029
6.3.2 US Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.3.3 Canada Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.3.4 Mexico Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Autologous Conditioned Plasma Therapy Revenue, 2018-2029
6.4.2 Germany Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4.3 France Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4.4 U.K. Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4.5 Italy Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4.6 Russia Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.4.8 Benelux Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Autologous Conditioned Plasma Therapy Revenue, 2018-2029
6.5.2 China Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.5.3 Japan Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.5.4 South Korea Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.5.6 India Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Autologous Conditioned Plasma Therapy Revenue, 2018-2029
6.6.2 Brazil Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.6.3 Argentina Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autologous Conditioned Plasma Therapy Revenue, 2018-2029
6.7.2 Turkey Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.7.3 Israel Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Autologous Conditioned Plasma Therapy Market Size, 2018-2029
6.7.5 UAE Autologous Conditioned Plasma Therapy Market Size, 2018-2029
7 Autologous Conditioned Plasma Therapy Companies Profiles
7.1 Zimmer Biomet Inc.
7.1.1 Zimmer Biomet Inc. Company Summary
7.1.2 Zimmer Biomet Inc. Business Overview
7.1.3 Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Major Product Offerings
7.1.4 Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.1.5 Zimmer Biomet Inc. Key News & Latest Developments
7.2 Terumo Corporation
7.2.1 Terumo Corporation Company Summary
7.2.2 Terumo Corporation Business Overview
7.2.3 Terumo Corporation Autologous Conditioned Plasma Therapy Major Product Offerings
7.2.4 Terumo Corporation Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.2.5 Terumo Corporation Key News & Latest Developments
7.3 AdiStem Ltd.
7.3.1 AdiStem Ltd. Company Summary
7.3.2 AdiStem Ltd. Business Overview
7.3.3 AdiStem Ltd. Autologous Conditioned Plasma Therapy Major Product Offerings
7.3.4 AdiStem Ltd. Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.3.5 AdiStem Ltd. Key News & Latest Developments
7.4 Arthrex, Inc.
7.4.1 Arthrex, Inc. Company Summary
7.4.2 Arthrex, Inc. Business Overview
7.4.3 Arthrex, Inc. Autologous Conditioned Plasma Therapy Major Product Offerings
7.4.4 Arthrex, Inc. Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.4.5 Arthrex, Inc. Key News & Latest Developments
7.5 Stryker Corporation
7.5.1 Stryker Corporation Company Summary
7.5.2 Stryker Corporation Business Overview
7.5.3 Stryker Corporation Autologous Conditioned Plasma Therapy Major Product Offerings
7.5.4 Stryker Corporation Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.5.5 Stryker Corporation Key News & Latest Developments
7.6 Cesca Therapeutics, Inc.
7.6.1 Cesca Therapeutics, Inc. Company Summary
7.6.2 Cesca Therapeutics, Inc. Business Overview
7.6.3 Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Major Product Offerings
7.6.4 Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.6.5 Cesca Therapeutics, Inc. Key News & Latest Developments
7.7 Biotechnology Institute BTI
7.7.1 Biotechnology Institute BTI Company Summary
7.7.2 Biotechnology Institute BTI Business Overview
7.7.3 Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Major Product Offerings
7.7.4 Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.7.5 Biotechnology Institute BTI Key News & Latest Developments
7.8 Dr. PRP America LLC
7.8.1 Dr. PRP America LLC Company Summary
7.8.2 Dr. PRP America LLC Business Overview
7.8.3 Dr. PRP America LLC Autologous Conditioned Plasma Therapy Major Product Offerings
7.8.4 Dr. PRP America LLC Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.8.5 Dr. PRP America LLC Key News & Latest Developments
7.9 EmCyte Corporation
7.9.1 EmCyte Corporation Company Summary
7.9.2 EmCyte Corporation Business Overview
7.9.3 EmCyte Corporation Autologous Conditioned Plasma Therapy Major Product Offerings
7.9.4 EmCyte Corporation Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.9.5 EmCyte Corporation Key News & Latest Developments
7.10 Vivostat A/S
7.10.1 Vivostat A/S Company Summary
7.10.2 Vivostat A/S Business Overview
7.10.3 Vivostat A/S Autologous Conditioned Plasma Therapy Major Product Offerings
7.10.4 Vivostat A/S Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.10.5 Vivostat A/S Key News & Latest Developments
7.11 Regen Lab SA
7.11.1 Regen Lab SA Company Summary
7.11.2 Regen Lab SA Business Overview
7.11.3 Regen Lab SA Autologous Conditioned Plasma Therapy Major Product Offerings
7.11.4 Regen Lab SA Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.11.5 Regen Lab SA Key News & Latest Developments
7.12 Royal Biologics
7.12.1 Royal Biologics Company Summary
7.12.2 Royal Biologics Business Overview
7.12.3 Royal Biologics Autologous Conditioned Plasma Therapy Major Product Offerings
7.12.4 Royal Biologics Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.12.5 Royal Biologics Key News & Latest Developments
7.13 Exactech, Inc.
7.13.1 Exactech, Inc. Company Summary
7.13.2 Exactech, Inc. Business Overview
7.13.3 Exactech, Inc. Autologous Conditioned Plasma Therapy Major Product Offerings
7.13.4 Exactech, Inc. Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.13.5 Exactech, Inc. Key News & Latest Developments
7.14 Plateltex S.R.O.
7.14.1 Plateltex S.R.O. Company Summary
7.14.2 Plateltex S.R.O. Business Overview
7.14.3 Plateltex S.R.O. Autologous Conditioned Plasma Therapy Major Product Offerings
7.14.4 Plateltex S.R.O. Autologous Conditioned Plasma Therapy Revenue in Global Market (2018-2023)
7.14.5 Plateltex S.R.O. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Autologous Conditioned Plasma Therapy Market Opportunities & Trends in Global Market
Table 2. Autologous Conditioned Plasma Therapy Market Drivers in Global Market
Table 3. Autologous Conditioned Plasma Therapy Market Restraints in Global Market
Table 4. Key Players of Autologous Conditioned Plasma Therapy in Global Market
Table 5. Top Autologous Conditioned Plasma Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Autologous Conditioned Plasma Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Autologous Conditioned Plasma Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Autologous Conditioned Plasma Therapy Product Type
Table 9. List of Global Tier 1 Autologous Conditioned Plasma Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Conditioned Plasma Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Autologous Conditioned Plasma Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Autologous Conditioned Plasma Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Autologous Conditioned Plasma Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Autologous Conditioned Plasma Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Autologous Conditioned Plasma Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Autologous Conditioned Plasma Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Zimmer Biomet Inc. Company Summary
Table 31. Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Product Offerings
Table 32. Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Zimmer Biomet Inc. Key News & Latest Developments
Table 34. Terumo Corporation Company Summary
Table 35. Terumo Corporation Autologous Conditioned Plasma Therapy Product Offerings
Table 36. Terumo Corporation Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Terumo Corporation Key News & Latest Developments
Table 38. AdiStem Ltd. Company Summary
Table 39. AdiStem Ltd. Autologous Conditioned Plasma Therapy Product Offerings
Table 40. AdiStem Ltd. Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. AdiStem Ltd. Key News & Latest Developments
Table 42. Arthrex, Inc. Company Summary
Table 43. Arthrex, Inc. Autologous Conditioned Plasma Therapy Product Offerings
Table 44. Arthrex, Inc. Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Arthrex, Inc. Key News & Latest Developments
Table 46. Stryker Corporation Company Summary
Table 47. Stryker Corporation Autologous Conditioned Plasma Therapy Product Offerings
Table 48. Stryker Corporation Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Stryker Corporation Key News & Latest Developments
Table 50. Cesca Therapeutics, Inc. Company Summary
Table 51. Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Product Offerings
Table 52. Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Cesca Therapeutics, Inc. Key News & Latest Developments
Table 54. Biotechnology Institute BTI Company Summary
Table 55. Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Product Offerings
Table 56. Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Biotechnology Institute BTI Key News & Latest Developments
Table 58. Dr. PRP America LLC Company Summary
Table 59. Dr. PRP America LLC Autologous Conditioned Plasma Therapy Product Offerings
Table 60. Dr. PRP America LLC Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Dr. PRP America LLC Key News & Latest Developments
Table 62. EmCyte Corporation Company Summary
Table 63. EmCyte Corporation Autologous Conditioned Plasma Therapy Product Offerings
Table 64. EmCyte Corporation Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. EmCyte Corporation Key News & Latest Developments
Table 66. Vivostat A/S Company Summary
Table 67. Vivostat A/S Autologous Conditioned Plasma Therapy Product Offerings
Table 68. Vivostat A/S Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Vivostat A/S Key News & Latest Developments
Table 70. Regen Lab SA Company Summary
Table 71. Regen Lab SA Autologous Conditioned Plasma Therapy Product Offerings
Table 72. Regen Lab SA Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Regen Lab SA Key News & Latest Developments
Table 74. Royal Biologics Company Summary
Table 75. Royal Biologics Autologous Conditioned Plasma Therapy Product Offerings
Table 76. Royal Biologics Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Royal Biologics Key News & Latest Developments
Table 78. Exactech, Inc. Company Summary
Table 79. Exactech, Inc. Autologous Conditioned Plasma Therapy Product Offerings
Table 80. Exactech, Inc. Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Exactech, Inc. Key News & Latest Developments
Table 82. Plateltex S.R.O. Company Summary
Table 83. Plateltex S.R.O. Autologous Conditioned Plasma Therapy Product Offerings
Table 84. Plateltex S.R.O. Autologous Conditioned Plasma Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Plateltex S.R.O. Key News & Latest Developments
List of Figures
Figure 1. Autologous Conditioned Plasma Therapy Segment by Type in 2022
Figure 2. Autologous Conditioned Plasma Therapy Segment by Application in 2022
Figure 3. Global Autologous Conditioned Plasma Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autologous Conditioned Plasma Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Autologous Conditioned Plasma Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autologous Conditioned Plasma Therapy Revenue in 2022
Figure 8. By Type - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 16. US Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 28. China Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Autologous Conditioned Plasma Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Autologous Conditioned Plasma Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Terumo Corporation Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AdiStem Ltd. Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Arthrex, Inc. Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Stryker Corporation Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dr. PRP America LLC Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. EmCyte Corporation Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vivostat A/S Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Regen Lab SA Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Royal Biologics Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Exactech, Inc. Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Plateltex S.R.O. Autologous Conditioned Plasma Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
